July 23, 2021
OINDPnews
Sorrento initiates Phase 2 trial of its intranasal neutralizing antibody against COVID-19
Sorrento Therapeutics has initiated a Phase 2 trial of its CoviDrops intranasal neutralizing antibody... See more »
2,682 Followers on Owler
Juno Therapeutics
Juno is a biopharmaceutical company that researches and develops cellular immunotherapies for the treatment of cancer.
Read more
CEO
Founded:
2013
Status:
PrivateSubsidiary of Bristol Myers Squibb Co
Est. Annual Revenue
Est. Employees
Sector
Headquarters
Missing a competitor? Contribute!
bluebird bio is the top competitor of Juno Therapeutics. bluebird bio was founded in 1992, and its headquarters is in Cambridge, Massachusetts. Like Juno Therapeutics, bluebird bio also operates in the Biotechnology field. bluebird bio has 550 more employees than Juno Therapeutics.
Trending News for Juno Therapeutics and Juno Therapeutics's Competitors
July 22, 2021
Contract Pharma
Minaris and bluebird bio Enter Manufacturing Pact
The CDMO will be the commercial manufacturer in Europe for Skysona, bluebird bio's gene therapy for C... See more »
July 21, 2021
Pharmabiz
BioNTech to buy Kite's Neoantigen TCR cell therapy R&D platform and manufacturing facility in Gaithersburg, Maryland
BioNTech SE and Kite, a Gilead Company announced the two companies have entered into a purchase agree... See more »
Juno Therapeutics Acquisitions
COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
Abvitro, Inc.
Jan 2016
Source »$78M
AbVitro is an immuno-oncology antibody discovery platform that allows for the discovery of cancer specific tumor infiltrating lymphocytes.
X-BODY Biosciences, Inc.
Jun 2015
Source »$21M
X-BODY Biosciences is a biotechnology firm that focuses on discovery of monoclonal antibodies against novel therapeutic.
These are all the companies that Juno Therapeutics has acquired. Juno Therapeutics has acquired 3 companies and its latest acquisition was RedoxTherapies, Inc in Jul 2016.
Juno Therapeutics Funding History
Since Juno Therapeutics was founded in 2013, it has participated in 6 rounds of funding. In total Juno Therapeutics has raised $1.5B. Juno Therapeutics' last funding round was on Sep 2017 for a total of $31.1M
ROUND
FUNDING DATE
AMOUNT
INVESTORS
IPO
Dec 2014
$264.6M
-
Series B
Jul 2014
$134M
Since Juno Therapeutics was founded in 2013, it has participated in 6 rounds of funding. In total Juno Therapeutics has raised $1.5B. Juno Therapeutics' last funding round was on Sep 2017 for a total of $31.1M
Juno Therapeutics Investments
FOLLOW STATUS
COMPANY
DESCRIPTION
AMOUNT
INVESTMENT DATE
ROUND
EXIT DATE
These are all the companies that Juno Therapeutics has invested in. Juno Therapeutics has invested 2 companies and its latest investment was JW Therapeutics in Jun 09,. JW Therapeutics is a biopharmaceutical company that develops and commercializes cell-based immunotherapies for the treatment of cancer.
Juno Therapeutics News
Juno Therapeutics Press Releases
Juno Therapeutics Videos
Social Media
Juno Therapeutics Headquarters
Trending Companies
IN THE NEWS
Reliance | Global Payments | Gilead | Avis Budget Group | PNC | PPG | John Deere | AT&T | Vanguard | Realty Income | Canadian Solar | MyoKardia | Sysco | Virtu Financial | United States Energy Association | Uber | Sony | Flexowash | MAA | Citi | Roper Technologies | Anaplan | Mercury Systems | Kraft Heinz | Epic Games | Galaxy ME | Brixmor | Vulcan Materials | CIBC | Marsh & McLennan | Accenture | Domino's Pizza | Apexwin | Nutanix | Ulta | Legal & General | Kiadis | URBN | Paychex | GE | Concho | Hocmai | Midwest Retail Properties | Merck | Skyworks | King | Toyota | Rcapital | Heathrow | Pomerantzlawfirm
PEOPLE ALSO VIEWED
Anda | Merck KGaA | Hyasynth Bio | Alvogen | Amgen Inc | Novozymes | Amneal | SCIEX | Evotec | Incyte | Tecan | Dendreon | Voyager | IQVIA | Glenmark | EventMobi | RTS Financial Service, Inc. | Cartesian Consulting | Izenda | Compal | DataCeutics | Roxane Laboratories | BIA Separations | Evestra | Applied Silver | Radisson Hotels | 4moms | VINYL I | Social Blade | QUANTIL
Juno Therapeutics Summary
ABOUT
Overview
Juno is a biopharmaceutical company that researches and develops cellular immunotherapies for the treatment of cancer. Juno Therapeutics was founded in 2013. Juno Therapeutics' headquarters is located in Seattle, Washington, USA 98109. It has raised 1...
Website
junotherapeutics.comFrequently Asked Questions about Juno Therapeutics
When was Juno Therapeutics founded?
Juno Therapeutics was founded in 2013How much revenue does Juno Therapeutics generate?
Juno Therapeutics generates $106M in revenueHow much funding does Juno Therapeutics have?
Juno Therapeutics has historically raised $1.5B in fundingWhere is Juno Therapeutics's headquarters?
Juno Therapeutics's headquarters is in Seattle Washington, USA
How many employees does Juno Therapeutics have?
Juno Therapeutics has 663 employeesWhat sector does Juno Therapeutics operate in?
Juno Therapeutics is in Biotechnology, PharmaceuticalsWho are Juno Therapeutics's competitors?
Juno Therapeutics's top competitors are bluebird bio, Celgene, Kite PharmaWho has Juno Therapeutics invested in?
Juno Therapeutics's has invested in companies such as JW Therapeutics, JW Therapeutics
